Clinical Trial Update: Vitamin D Supplementation in CAD and Postchallenge Hyperglycemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating vitamin D supplementation for coronary artery disease and postprandial hyperglycemia has terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Postprandial Hyperglycemia

Drugs mentioned

• Vitamin D (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Medical University of Graz | Conditions: Coronary Artery Disease, Postprandial Hyperglycemia | Phase 3 | Status: TERMINATED